Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
AVTR 
Avantor Inc (AVTR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: AVTR (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -25.18% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 11.04B USD | Price to earnings Ratio 15.59 | 1Y Target Price 24.48 |
Price to earnings Ratio 15.59 | 1Y Target Price 24.48 | ||
Volume (30-day avg) 7698685 | Beta 1.3 | 52 Weeks Range 15.37 - 28.00 | Updated Date 04/2/2025 |
52 Weeks Range 15.37 - 28.00 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.04 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 10.49% | Operating Margin (TTM) 16.41% |
Management Effectiveness
Return on Assets (TTM) 3.61% | Return on Equity (TTM) 12.7% |
Valuation
Trailing PE 15.59 | Forward PE 15.43 | Enterprise Value 14839746081 | Price to Sales(TTM) 1.59 |
Enterprise Value 14839746081 | Price to Sales(TTM) 1.59 | ||
Enterprise Value to Revenue 2.19 | Enterprise Value to EBITDA 10.04 | Shares Outstanding 680902976 | Shares Floating 677668285 |
Shares Outstanding 680902976 | Shares Floating 677668285 | ||
Percent Insiders 1.29 | Percent Institutions 103.31 |
Analyst Ratings
Rating 4.14 | Target Price 27.12 | Buy 7 | Strong Buy 9 |
Buy 7 | Strong Buy 9 | ||
Hold 6 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Avantor Inc
Company Overview
History and Background
Avantor, Inc. (formerly known as VWR Corporation) was founded in 1904. It evolved from a chemical supply business to a leading global provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
Core Business Areas
- Materials and Consumables: Offers a broad range of high-purity chemicals, lab products, consumables, and equipment used in research, development, and production. Includes chromatography products, cell culture products, and personal protective equipment.
- Equipment and Instrumentation: Provides laboratory and production equipment, instruments, and related services, including installation, maintenance, and repair.
- Services and Specialty Solutions: Offers a range of services including single-use solutions, clinical services, bioprocessing services, and custom kitting & formulation.
Leadership and Structure
Avantor is led by President and CEO Michael Stubblefield. The company has a typical corporate structure with various departments and functional teams reporting to the executive leadership.
Top Products and Market Share
Key Offerings
- High-Purity Chemicals: Avantor manufactures and distributes high-purity chemicals used in various applications, including pharmaceuticals and microelectronics. Competitors include Merck KGaA and Thermo Fisher Scientific. Difficult to find exact market share data.
- Single-Use Solutions: Offers single-use bioprocessing solutions for biopharmaceutical manufacturing. The market for single-use technologies is growing rapidly. Competitors include Sartorius Stedim Biotech and Danaher Corporation (Cytiva).
- Laboratory Equipment: Avantor provides laboratory equipment like centrifuges, incubators and analytical tools to research facilities and manufacturing firms. Competitors include Thermo Fisher Scientific and Agilent Technologies. Difficult to find exact market share data.
Market Dynamics
Industry Overview
The life sciences and advanced technologies industries are growing, driven by increasing research and development spending, biopharmaceutical innovation, and the demand for advanced materials.
Positioning
Avantor is positioned as a leading global provider of mission-critical products and services. Its competitive advantages include its broad product portfolio, global footprint, and strong customer relationships.
Total Addressable Market (TAM)
The TAM is estimated to be hundreds of billions of dollars. Avantor is well-positioned to capture a significant share of this market due to its diverse product offerings and global reach.
Upturn SWOT Analysis
Strengths
- Broad product portfolio
- Global footprint
- Strong customer relationships
- Integrated supply chain
- Focus on innovation
Weaknesses
- Exposure to cyclical industries
- Integration risks from acquisitions
- Dependence on key suppliers
- Debt load
Opportunities
- Expanding into emerging markets
- Acquiring complementary businesses
- Developing new products and services
- Increasing demand for biopharmaceuticals
Threats
- Economic downturns
- Increased competition
- Supply chain disruptions
- Regulatory changes
- Fluctuations in currency exchange rates
Competitors and Market Share
Key Competitors
- TMO
- DHR
- SMCI
Competitive Landscape
Avantor competes with larger and smaller companies across its various business segments. Its advantages include a broad product portfolio and strong customer relationships, while its disadvantages can include size and debt.
Major Acquisitions
Masterflex Bioprocessing
- Year: 2021
- Acquisition Price (USD millions): 2300
- Strategic Rationale: Strengthened Avantor's single-use solutions offering for bioprocessing applications.
Growth Trajectory and Initiatives
Historical Growth: Avantor has grown through organic growth and acquisitions.
Future Projections: Future growth projections would be based on analyst estimates from sources like Yahoo Finance or Bloomberg.
Recent Initiatives: Recent initiatives include acquisitions to expand product offerings and geographic reach.
Summary
Avantor is a globally positioned company in the life sciences and advanced technologies space with a diverse product offering and customer base. While its strategic acquisitions have fueled growth, it also carries a significant debt load that needs to be managed. The company should continue focusing on innovation and expanding into high-growth markets. Potential supply chain disruptions and increased competition represent ongoing challenges.
Similar Companies
DHR
Danaher Corporation
DHR
Danaher Corporation
SMCI
Super Micro Computer Inc
SMCI
Super Micro Computer Inc
TMO
Thermo Fisher Scientific Inc
TMO
Thermo Fisher Scientific Inc
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Company Website
- Analyst Reports
- Market Research Reports
- Financial News Outlets
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance can change, so conduct thorough research before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Avantor Inc
Exchange NYSE | Headquaters Radnor, PA, United States | ||
IPO Launch date 2019-05-17 | President, CEO & Director Mr. Michael Stubblefield | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 13500 | Website https://www.avantorsciences.com |
Full time employees 13500 | Website https://www.avantorsciences.com | ||
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.